For the second time in 6 months, the Centers for Medicare & Medicaid Services officials have revised readmission penalties for hospitals. In doing so, approximately 1200 hospitals are now subject to lesser penalties.
For the second time in 6 months, the Centers for Medicare & Medicaid Services (CMS) officials have revised readmission penalties for hospitals. In doing so, approximately 1200 hospitals are now subject to lesser penalties.
The new corrections include decreased penalties for 1246 hospitals and increased penalties for 226 hospitals, resulting in a total of $280 million in penalties, which is approximately $10 million less than previously calculated. Kaiser Health News also released the following information following an analysis of the new data:
According to Jonathan Blum, Acting Principal Deputy Administrator and Director, Center for Medicare and CMS, stated that “This decrease is an early sign that our payment and delivery reforms are having an impact.” Kaiser Health News adds that “Under the program, the government is looking at the number of heart attack, heart failure, and pneumonia patients who return to the hospital within 30 days of discharge,” and that “hospitals with more readmissions than Medicare expected given their mix of patients are penalized by losing up to 1% of their regular payments.”
Around the Web
Medicare Revises Readmissions Penalties — Again [Kaiser Health News]
CMS Revises Hospitals' Readmission Penalties for the Second Time [Becker’s Hospital Review]
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More